SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Mori Janice Satsumi (Last) (First) (Middle) C/O SYNAPTICS INCORPORATED 1251 MCKAY DRIVE (Street) SAN JOSE CA 95131 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 12/09/2019	3. Issuer Name and Ticker or Trading Symbol SYNAPTICS Inc [ SYNA ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) See Remarks	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	15,609(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	(2)	10/28/2020	Common Stock	276	46.5	D
Employee Stock Option (Right to Buy)	(2)	01/27/2021	Common Stock	827	60.22	D
Employee Stock Option (Right to Buy)	(2)	04/28/2021	Common Stock	827	61.4	D
Employee Stock Option (Right to Buy)	(2)	08/01/2021	Common Stock	827	78.11	D
Employee Stock Option (Right to Buy)	(2)	10/24/2021	Common Stock	537	62.105	D
Employee Stock Option (Right to Buy)	(2)	01/30/2022	Common Stock	537	76.81	D
Employee Stock Option (Right to Buy)	(2)	04/24/2022	Common Stock	537	85.69	D
Employee Stock Option (Right to Buy)	(2)	07/31/2022	Common Stock	536	79.38	D
Employee Stock Option (Right to Buy)	(2)	10/23/2022	Common Stock	749	89.29	D
Employee Stock Option (Right to Buy)	(2)	01/29/2023	Common Stock	750	73.1	D
Employee Stock Option (Right to Buy)	(2)	04/29/2023	Common Stock	750	71.55	D
Employee Stock Option (Right to Buy)	(2)	07/29/2023	Common Stock	750	51.95	D

Explanation of Responses:

1. Includes (i) 711 shares that were acquired pursuant to the Issuer's Employee Stock Purchase Plan; (ii) 3,208 shares that were acquired upon delivery of vested restricted stock units; (iii) 186 shares released in connection with the vesting of performance-based market stock units granted on December 13, 2017; (iv) 593 shares released in connection with the vesting of performance stock units granted on December 13, 2017; and (v) 10,911 shares underlying restricted stock units that are not yet vested and deliverable.

2. The options are fully vested.

Remarks:

The reporting person is the Senior Vice President and General Manager, Touch and Display. Exhibit List Exhibit 24 - Limited Power of Attorney

	/s/ Kermit Nolan, as Attorney-in-Fact	12/11/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS


Know all by these presents, that the undersigned hereby makes, constitutes and
appoints each of John McFarland, Megha Aggarwal and Kermit Nolan as the
undersigned's true and lawful attorney-in-fact, with full power and authority as
hereinafter described on behalf of and in the name, place and stead of the
undersigned to:

(1)	prepare, execute, acknowledge, deliver and file Forms 3, 4 and 5 (including
any amendments thereto) with respect to the securities of Synaptics
Incorporated, a Delaware corporation (the "Company"), with the United States
Securities and Exchange Commission, any national securities exchanges and the
Company, as considered necessary or advisable under Section 16(a) of the
Securities Exchange Act of 1934 and the rules and regulations promulgated
thereunder, as amended from time to time (the "Exchange Act");

(2)	seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information on transactions in the Company's securities from any third
party, including brokers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such person to release any such
information to the undersigned and approves and ratifies any such release of
information; and

(3)	perform any and all other acts which in the discretion of such
attorney-in-fact are necessary or desirable for and on behalf of the undersigned
in connection with the foregoing.

The undersigned acknowledges that:

(1)	this Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in their discretion on information provided to such
attorney-in-fact without independent verification of such information;

(2)	any documents prepared and/or executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney will be in such form and will
contain such information and disclosure as such attorney-in-fact, in his or her
discretion, deems necessary or desirable;

(3)	neither the Company nor such attorney-in-fact assumes (i) any liability for
the undersigned's responsibility to comply with the requirement of the Exchange
Act,  (ii) any liability of the undersigned for any failure to comply with such
requirements, or (iii) any obligation or liability of the undersigned for profit
disgorgement under Section 16(b) of the Exchange Act; and

(4)	this Power of Attorney does not relieve the undersigned from responsibility
for compliance with the undersigned's obligations under the Exchange Act,
including without limitation the reporting requirements under Section 16 of the
Exchange Act.

The undersigned hereby gives and grants the foregoing attorney-in-fact full
power and authority to do and perform all and every act and thing whatsoever
requisite, necessary or appropriate to be done in and about the foregoing
matters as fully to all intents and purposes as the undersigned might or could
do if present, hereby ratifying all that such attorney-in-fact of, for and on
behalf of the undersigned, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney.

This Power of Attorney supersedes any and all previous powers of attorney
executed with regards to the same subject matter as agreed to herein. This Power
of Attorney shall remain in full force and effect until revoked by the
undersigned in a signed writing delivered to such attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 4th day of December, 2019.

/s/ Janice Mori
Janice Mori